QUOTE AND NEWS
Market Intelligence Center  May 20  Comment 
RADWARE (NASDAQ: RDWR) closed Friday's trading session at $15.74. In the past year, the stock has hit a 52-week low of $13.38 and 52-week high of $20.01. RADWARE (RDWR) stock has been showing support around $15.45 and resistance in the $16.11...
Market Intelligence Center  May 14  Comment 
RADWARE (NASDAQ: RDWR) closed Monday's trading session at $15.35. In the past year, the stock has hit a 52-week low of $13.38 and 52-week high of $20.42. RADWARE (RDWR) stock has been showing support around $15.04 and resistance in the $15.66...
Market Intelligence Center  May 8  Comment 
RADWARE (NASDAQ: RDWR) closed Tuesday's trading session at $15.11. In the past year, the stock has hit a 52-week low of $13.38 and 52-week high of $20.42. RADWARE (RDWR) stock has been showing support around $14.82 and resistance in the $15.48...
Benzinga  Apr 25  Comment 
Radware (NASDAQ: RDWR) today announced that its board of directors has authorized a share repurchase plan allowing the repurchase of up to $40 million of ordinary shares. Share purchases will take place in open market transactions or in...
Cloud Computing  Apr 25  Comment 
TEL AVIV, Israel , April 25, 2013 /PRNewswire/ -- read more
Market Intelligence Center  Apr 22  Comment 
RADWARE (NASDAQ: RDWR) closed Friday's trading session at $13.89. In the past year, the stock has hit a 52-week low of $13.38 and 52-week high of $20.42. RADWARE (RDWR) stock has been showing support around $13.55 and resistance in the $14.25...
Market Intelligence Center  Apr 11  Comment 
RADWARE (NASDAQ: RDWR) closed Wednesday's trading session at $29.38. In the past year, the stock has hit a 52-week low of $26.76 and 52-week high of $40.83. RADWARE (RDWR) stock has been showing support around $28.80 and resistance in the $30.08...
StreetInsider.com  Apr 5  Comment 
Rigel Pharmaceuticals (Nasdaq: RIGL) 35.5% LOWER; AstraZeneca announced top-line results of OSKIRA-1, a Phase 3 study to assess the efficacy and safety of fostamatinib, the first oral spleen tyrosine kinase (SYK) inhibitor in development for...
Benzinga  Apr 5  Comment 
Midway through trading Friday, the Dow traded down 0.79 percent to 14,490.91 while the NASDAQ dropped 1.11 percent to 3,189.33. The S&P also fell, declining 0.94 percent to 1,545.39. Index Technicals: The S&P 500 found support at 1,550...
Benzinga  Apr 5  Comment 
In a report published Friday, Oppenheimer analyst Ittai Kidron reiterated an Outperform rating on Radware Ltd. (NASDAQ: RDWR), but lowered the price target from $43.00 to $35.00. In the report, Kidron noted, “Despite our positive checks on...




RELATED WIKI ARTICLES

Related Articles

 
TOP CONTRIBUTORS

Headquartered at Tel Aviv, Israel, Radware Ltd. (RDWR) develops and markets Intelligent Application Switching (IAS) solutions, previously termed Internet traffic management solutions. The company offers solutions to service providers, e-commerce enterprises, and corporate houses to improve the productivity of network infrastructures through optimum utilization of available network resources. Radware also providesAPSolute Insight, an application management tool which offers a set of user defined statistics that provide bandwidth and consumption data per device including bi-directional traffic, failures, bottlenecks, resource management and client information. In 1999, the company established a wholly owned subsidiary in the U.S., Radware Inc., for conducting marketing and sales activities in the North American region. Between 2000 and 2003, Radware Ltd. developed subsidiaries and representative offices in most parts of Europe, along with China and Southeast Asia, for marketing promotions and customer support services.




References

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki